Marcus Herdener

University of Zurich

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (16)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Collaborators (12)

Mengfan Zhang

Universität Wien

AUSTRIA

View details

Frank Scharnowski

Universität Wien

AUSTRIA

View details

Marta Torrens

Parc de Salut

SPAIN

View details

Matthias Kirschner

University of Geneva

SWITZERLAND

View details

Boris B. Quednow

Associate Professor

University of Zurich

SWITZERLAND

View details

Narly Golestani

Prof.

Universität Wien

AUSTRIA

View details

Ronald Sladky

Universität Wien

AUSTRIA

View details

Marc Vogel

SWITZERLAND

View details

Bartolome Perez-Galvez

Profesor asociado Psiquiatría

Universidad Miguel Hernandez de Elche - Campus San Juan de Alicante

SPAIN

View details

Nan-kuei Chen

Associate Professor

University of Arizona

UNITED STATES

View details

Cindy, Sumaly Lor

Universität Wien

AUSTRIA

View details

Lydia Hellrung

University of Zurich

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Marcus Herdener

Research Interests

Explore related searches

Contact this professor

Articles (16)

Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial

Co-Boost: boosting and guiding neuroplasticity by combining ketamine with neurofeedback-assisted learning-towards an individualised and integrated pharmaco-psychotherapy for cocaine addiction: study protocol for a randomised, placebo-controlled, double-blind, parallel-group, single-centre trial.

The emotional architecture of the psychedelic brain.

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

<i>N</i>-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder.

The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol.

Thalamic volume and functional connectivity are associated with nicotine dependence severity and craving

Analysis of individual differences in neurofeedback training illuminates successful self-regulation of the dopaminergic midbrain.

Disentangling craving‐ and valence‐related brain responses to smoking cues in individuals with nicotine use disorder

Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.

Neurometabolic alterations in the nucleus accumbens of smokers assessed with 1H magnetic resonance spectroscopy: The role of glutamate and neuroinflammation

Neural mapping of anhedonia across psychiatric diagnoses: A transdiagnostic neuroimaging analysis.

Predictors of real-time fMRI neurofeedback performance and improvement - A machine learning mega-analysis.

Use of psychotropic substances among elite athletes - a narrative review.

Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophrenia.

SmoCuDa: A Validated Smoking Cue Database to Reliably Induce Craving in Tobacco Use Disorder.

Collaborators (12)

Mengfan Zhang

Frank Scharnowski

Marta Torrens

Matthias Kirschner

Boris B. Quednow

Narly Golestani

Ronald Sladky

Marc Vogel

Bartolome Perez-Galvez

Nan-kuei Chen

Cindy, Sumaly Lor

Lydia Hellrung

Make your next move.

Marcus Herdener

Research Interests

Explore related searches

Contact this professor

Articles (16)

Mavoglurant reduces cocaine use in patients with cocaine use disorder in a phase 2 clinical trial

Co-Boost: boosting and guiding neuroplasticity by combining ketamine with neurofeedback-assisted learning-towards an individualised and integrated pharmaco-psychotherapy for cocaine addiction: study protocol for a randomised, placebo-controlled, double-blind, parallel-group, single-centre trial.

The emotional architecture of the psychedelic brain.

Psilocybin-assisted therapy for relapse prevention in alcohol use disorder: a phase 2 randomized clinical trial.

&lt;i&gt;N&lt;/i&gt;-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder.

The Züri Can study: Can regulated cannabis sales promote lower-risk cannabis use? Mini-review and study protocol.

Thalamic volume and functional connectivity are associated with nicotine dependence severity and craving

Analysis of individual differences in neurofeedback training illuminates successful self-regulation of the dopaminergic midbrain.

Disentangling craving‐ and valence‐related brain responses to smoking cues in individuals with nicotine use disorder

Psychedelic-Assisted Therapy for Substance Use Disorders and Potential Mechanisms of Action.

Neurometabolic alterations in the nucleus accumbens of smokers assessed with 1H magnetic resonance spectroscopy: The role of glutamate and neuroinflammation

Neural mapping of anhedonia across psychiatric diagnoses: A transdiagnostic neuroimaging analysis.

Predictors of real-time fMRI neurofeedback performance and improvement - A machine learning mega-analysis.

Use of psychotropic substances among elite athletes - a narrative review.

Aberrant striatal coupling with default mode and central executive network relates to self-reported avolition and anhedonia in schizophrenia.

SmoCuDa: A Validated Smoking Cue Database to Reliably Induce Craving in Tobacco Use Disorder.

Collaborators (12)

Mengfan Zhang

Frank Scharnowski

Marta Torrens

Matthias Kirschner

Boris B. Quednow

Narly Golestani

Ronald Sladky

Marc Vogel

Bartolome Perez-Galvez

Nan-kuei Chen

Cindy, Sumaly Lor

Lydia Hellrung

Make your next move.

<i>N</i>-acetylcysteine reduces prefrontal reactivity to cocaine cues in individuals with cocaine use disorder.